Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients
Completed
- Conditions
- Covid19
- Interventions
- Diagnostic Test: Blood coagulation profile
- Registration Number
- NCT04982263
- Lead Sponsor
- Sohag University
- Brief Summary
The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed
- Detailed Description
In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
● Confirmed cases with COVID 19
Exclusion Criteria
● Known history of blood coagulopathy disorder
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Mild cases Blood coagulation profile Patients with confirmed COVID-19 and with mild disease Severe cases Blood coagulation profile Patients with confirmed COVID-19 and with severe disease
- Primary Outcome Measures
Name Time Method correlation of disease severity with results of laboratory test Baseline results of coagulation profile and baseline disease severity assessment The results of blood coagulation profile will be correlated with degree of severity of illness
- Secondary Outcome Measures
Name Time Method Agreement of abnormalities in coagulation profile with measured inflammatory markers baseline measurement of inflammatory markers The inflammatory markers will be measured and correlation with abnormalities in coagulation profile will be assessed
Trial Locations
- Locations (1)
Sohag University
🇪🇬Sohag, Egypt